In the context of new anti-obesity medications, the American College of Cardiology has issued a Scientific Statement updating ...

A new obesity drug combining four hormones may outperform Wegovy and Mounjaro. Learn what it means for health, science, and investors.

A federal judge in Texas has upheld the FDA’s decision to remove GLP-1 drugs, including Novo Nordisk’s Ozempic and Wegovy, from its drug shortage list, rejecting a bid by compounding pharmacies to ...

Early trials found that both garadacimab and sebetralstat were safe when used in patients living with hereditary angioedema, ...